Concepedia

Anzu Hamaguchi

AH

Statistics

Publications

3

Citations

186

H-Index

3

Active since

2004

Affiliations

University College London(Current)

Cancer Research UK

Spirogen (United Kingdom)

Anzu Hamaguchi is an author at University College London specializing in drug development, drug discovery, and medicinal chemistry.

Top concepts

MedicinePharmacologyDrug DiscoveryDrug DevelopmentNatural SciencesMolecular BiologyMedicinal ChemistryTumor BiologyPharmacotherapyChemical Biology

Publications per year

2004–2011

3

Publications

3

Linker Length Modulates DNA Cross-Linking Reactivity and Cytotoxic Potency of C8/C8‘ Ether-Linked C2-<i>exo</i>-Unsaturated Pyrrolo[2,1-<i>c</i>][1,4]benzodiazepine (PBD) Dimers

Stephen J. Gregson, Philip W. Howard, Darren R. Gullick et al. · Journal of Medicinal Chemistry · 2004 · 92 citations

SG2285, a Novel C2-Aryl-Substituted Pyrrolobenzodiazepine Dimer Prodrug That Cross-links DNA and Exerts Highly Potent Antitumor Activity

John A. Hartley, Anzu Hamaguchi, Marissa Coffils et al. · Cancer Research · 2010 · 59 citations · Full text

Drug Target, Chemoprevention Strategy, Molecular Biology +16

DNA interstrand cross-linking and in vivo antitumor activity of the extended pyrrolo[2,1-c][1,4]benzodiazepine dimer SG2057

John A. Hartley, Anzu Hamaguchi, Marie Suggitt et al. · Investigational New Drugs · 2011 · 35 citations

Dna Interstrand Cross-linking, Medicinal Chemistry, Nucleic Acid Chemistry +10

1–3 of 3